BBOT

AS OF

Dec 24 closing price

Price

$12.20

Change

+$0.27 (+2.26%)

Capitalization

975.86M

62 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

BBOT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BridgeBio Oncology Therapeutics (BBOT) Ownership - Who owns BridgeBio Oncology Therapeutics?

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

BBOT

Capitalization

976M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

468M

Total Cash/Share

5.85

Total Debt

2.89M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

447M

P/B Ratio

2.18

Cash Flow

N/A

Earnings

-1.45

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

13.33

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-123.82M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-23.71

Shares Held By Institutions

680M

Shares Outstanding - Current

80M

Total Liabilities

38.1M

Total Volume MTD

N/A

Value

Gain YTD

16.190

View a ticker or compare two or three

Compare

BBOT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for BBOT

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details